{"id":"W2060221163","doi":"10.1007/s12325-012-0037-5","title":"Treatment Patterns in the First Year After Initiating Tumor Necrosis Factor Blockers in Real-World Settings","year":2012,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"ca_institutions":"Thomson Reuters (Canada)","funders":"Pfizer; Amgen","keywords":"Etanercept; Medicine; Adalimumab; Infliximab; Golimumab; Psoriatic arthritis; Rheumatoid arthritis; Internal medicine; Abatacept; Ankylosing spondylitis; Psoriasis; Ustekinumab; Tumor necrosis factor alpha; Rituximab; Dermatology; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00137199,0.000214924,0.000499832,0.001206332,0.0004537219,0.001125761,0.0005374308,0.0005985901,0.001283993],"category_scores_gemma":[0.00419742,0.0002202526,0.0006924995,0.001590593,0.0002832035,0.0006096878,0.000621519,0.0008033706,0.000236548],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008845439,"about_ca_system_score_gemma":0.0007341862,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007519461,"about_ca_topic_score_gemma":0.01106469,"domain_scores_codex":[0.9980773,0.0004705576,0.0003253232,0.0004549395,0.0003132293,0.0003586682],"domain_scores_gemma":[0.9903302,0.001023859,0.007294782,0.0002140278,0.0003679972,0.0007691254],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001842354,0.00003184788,0.9987821,0.00001039876,0.00004355456,0.0000607834,0.00004697287,0.00004763288,0.00005489909,0.00001303301,0.00009963541,0.000624811],"study_design_scores_gemma":[0.00001793556,0.0001308774,0.9987487,0.00001273478,0.00002809584,0.0003247972,0.000188928,0.0002426131,0.0000452618,0.00001540832,0.0002376596,0.000006922719],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980002,0.0004828957,0.00006818293,0.00006254933,0.000007423133,0.00001517999,0.0009825443,0.000004365537,0.0003766204],"genre_scores_gemma":[0.9988488,0.0001217493,0.00007091237,0.0000412633,0.00001167323,0.00001711882,0.0008093044,0.000001608268,0.00007768928],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007519461,"threshold_uncertainty_score":0.01495135,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02027643044986484,"score_gpt":0.3219488934943859,"score_spread":0.3016724630445211,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}